Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Nature Reviews. Neuroscience|December 21, 2012
The many faces of α-synuclein: from structure and toxicity to therapeutic targetHilal A Lashuel, Cassia R Overk, Abid Oueslati, et al.Heliyon|November 5, 2024
Pharmacological inhibition of PLK2 kinase activity mitigates cognitive decline but aggravates APP pathology in a sex-dependent manner in APP/PS1 mouse model of Alzheimer's diseaseLaura Martínez-Drudis, Morgan Bérard, Dylan Musiol, et al.Experimental Neurology|May 10, 2026
The emerging role of polo-like kinase 2 in Alzheimer's diseaseLaura Martínez-Drudis, Razan Sheta, Dylan Musiol, et al.Frontiers in Aging Neuroscience|January 7, 2025
Behavioral analysis of motor and non-motor impairment in rodent models of Parkinson's diseaseRazan Sheta, Morgan Bérard, Dylan Musiol, et al.The European Journal of Neuroscience|December 6, 2005
Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonismAbid Oueslati, Nathalie Breysse, Marianne Amalric, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 4, 2012
Mimicking phosphorylation at serine 87 inhibits the aggregation of human α-synuclein and protects against its toxicity in a rat model of Parkinson's diseaseAbid Oueslati, Katerina E Paleologou, Bernard L Schneider, et al.The European Journal of Neuroscience|September 29, 2006
Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmissionPaolo Gubellini, Alexandre Eusebio, Abid Oueslati, et al.Neurobiology of Disease|July 21, 2009
Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapiesEmilie Lacombe, Vitaly Khaindrava, Christophe Melon, et al.Molecular Neurodegeneration|November 28, 2023
Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson's disease in rodent brainsMorgan Bérard, Laura Martínez-Drudis, Razan Sheta, et al.Iscience|July 4, 2025
Combining light-induced aggregation and biotin proximity labeling implicates endolysosomal proteins in early α-synuclein oligomerizationMaxime Teixeira, Razan Sheta, Dylan Musiol, et al.Pageof 5